|

Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

RECRUITINGSponsored by Helios Klinikum Pforzheim
Actively Recruiting
SponsorHelios Klinikum Pforzheim
Started2020-11-30
Est. completion2025-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05179616

Summary

The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
* Subjects eligible to receive the TriClip™
* Subjects must provide written informed consent prior to study procedure.

Exclusion Criteria:

* Subjects participating in another clinical study that may impact the follow-up or results of this study.

Conditions5

Cardiac Remodeling, AtrialCardiac Remodeling, VentricularHeart DiseaseRight Heart FailureTricuspid Regurgitation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.